About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6444206
Allelic
Composition
Psaptm2.1Juma/Psaptm2.1Juma
Genetic
Background
involves: 129 * C57BL/6J * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Psaptm2.1Juma mutation (0 available); any Psap mutation (36 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• mice develop progressive motor and behavioral deficit after 3 months of age
• mice show limb-clasping reflexes at around 6-8 months of age
• tremors progress over time
• mice show severely impaired motor coordination on the rotarod at 4 months of age, showing shorter staying times on the rod
• gait disturbance progresses such that mice can hardly move at terminal stage of around 15 months

nervous system
• progressive loss of cerebellar Purkinje cells; Purkinje cell loss is first seen in the first cerebellar lobule at about 3 months of age and majority are lost by 12 months of age, remaining only in the 10th cerebellar lobule
• loss of Purkinje cell bodies and dendrites is patterned and selective
• cells with eosinophilic cytoplasm and condensed nuclei are seen in the granule layer, suggesting apoptosis
• the perikarya of cerebellar granule cells exhibits accumulation of lipofuscin-like electron-dense material
• the number of granule cells is the granule layer is decreased
• scattered PAS+ macrophages/microglia are seen in the molecular layer of the cerebellum
• however, GABAergic interneurons in the molecular layer are similar to wild-type mice
• activated astrocytes are seen in areas of Purkinje cell loss
• trigeminal nerve shows ganglion cells with inclusion bodies; storage materials consist of many soap-bubble-like inclusions surrounded by membranes
• foamy inclusions are seen in the non-neuronal vascular endothelial cells in the cerebellum
• however, no pathological lesions including neuronal storage are seen in the cerebral cortex, hippocampus, thalamus, amygdala, caudate/putamen and substantia nigra and no signs of demyelination are seen in the central or peripheral nervous system
• axonal spheroids are evident in the cerebellar granular layers, brain stems, and in the dorsal horn of spinal cords
• spheroids consist of axons filled with membrane-derived concentric or lamellar bodies often containing mitochondria-like structures

cardiovascular system
• foamy inclusions are seen in the non-neuronal vascular endothelial cells in the cerebellum

homeostasis/metabolism
N
• no accumulation of glucosylceramide is seen in the brain and liver, even at terminal stage of about 12 months and no major abnormalities in profiles of other lipids are seen
• activity of glucosylceramidase is lower
• however, activity of GM1-ganglioside beta-galactosidase and beta-hexaminidase is unchanged

hematopoietic system
N
• mice show no signs of hepatosplenomegaly throughout life and spleen shows no changes

liver/biliary system
N
• mice show no signs of hepatosplenomegaly throughout life and liver shows no changes

reproductive system
N
• mice are fertile and testis are normal

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
NOT Gaucher's disease DOID:1926 J:283977


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory